BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Ploug T, Holm S. Clinical genome sequencing and population preferences for information about 'incidental' findings-From medically actionable genes (MAGs) to patient actionable genes (PAGs). PLoS One 2017;12:e0179935. [PMID: 28671958 DOI: 10.1371/journal.pone.0179935] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 3.8] [Reference Citation Analysis]
Number Citing Articles
1 Mena C, Terry S. No Seat at the Recommendations Table? Genet Test Mol Biomarkers 2018;22:3-4. [PMID: 29345983 DOI: 10.1089/gtmb.2017.29039.sjt] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
2 Lekstutiene J, Holm S, Gefenas E. Biobanks and Individual Health Related Findings: from an Obstacle to an Incentive. Sci Eng Ethics 2021;27:55. [PMID: 34379215 DOI: 10.1007/s11948-021-00330-9] [Reference Citation Analysis]
3 Mighton C, Clausen M, Sebastian A, Muir SM, Shickh S, Baxter NN, Scheer A, Glogowski E, Schrader KA, Thorpe KE, Kim THM, Lerner-Ellis J, Kim RH, Regier DA, Bayoumi AM, Bombard Y. Patient and public preferences for being recontacted with updated genomic results: a mixed methods study. Hum Genet 2021;140:1695-708. [PMID: 34537903 DOI: 10.1007/s00439-021-02366-0] [Reference Citation Analysis]
4 Jiang S, Anis AH, Cromwell I, Mohammadi T, Schrader KA, Lucas J, Armour CM, Clausen M, Bombard Y, Regier DA. Health-care practitioners' preferences for the return of secondary findings from next-generation sequencing: a discrete choice experiment. Genet Med 2020;22:2011-9. [PMID: 32820245 DOI: 10.1038/s41436-020-0927-x] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
5 Parker LS, Sankar PL, Boyer J, Jean Mcewen J, Kaufman D. Normative and conceptual ELSI research: what it is, and why it’s important. Genet Med 2019;21:505-9. [DOI: 10.1038/s41436-018-0065-x] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
6 Godino L, Varesco L, Bruno W, Bruzzone C, Battistuzzi L, Franiuk M, Miccoli S, Bertonazzi B, Graziano C, Seri M, Turchetti D. Preferences of Italian patients for return of secondary findings from clinical genome/exome sequencing. J Genet Couns 2021;30:665-75. [PMID: 33142017 DOI: 10.1002/jgc4.1350] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
7 Boardman F, Hale R. Responsibility, identity, and genomic sequencing: A comparison of published recommendations and patient perspectives on accepting or declining incidental findings. Mol Genet Genomic Med 2018;6:1079-96. [PMID: 30370638 DOI: 10.1002/mgg3.485] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 2.3] [Reference Citation Analysis]
8 Etchegary H, Pullman D, Simmonds C, Rahman P. Public interest in unexpected genomic findings: a survey study identifying aspects of sequencing attitudes that influence preferences. J Community Genet. [DOI: 10.1007/s12687-022-00577-0] [Reference Citation Analysis]
9 Sebastian A, Carroll JC, Vanstone M, Clausen M, Kodida R, Reble E, Mighton C, Shickh S, Aronson M, Eisen A, Elser C, Lerner-Ellis J, Kim RH, Bombard Y. Widening the lens of actionability: A qualitative study of primary care providers' views and experiences of managing secondary genomic findings. Eur J Hum Genet 2021. [PMID: 33776058 DOI: 10.1038/s41431-021-00876-z] [Reference Citation Analysis]
10 Shickh S, Clausen M, Mighton C, Casalino S, Joshi E, Glogowski E, Schrader KA, Scheer A, Elser C, Panchal S, Eisen A, Graham T, Aronson M, Semotiuk KM, Winter-Paquette L, Evans M, Lerner-Ellis J, Carroll JC, Hamilton JG, Offit K, Robson M, Thorpe KE, Laupacis A, Bombard Y. Evaluation of a decision aid for incidental genomic results, the Genomics ADvISER: protocol for a mixed methods randomised controlled trial. BMJ Open 2018;8:e021876. [PMID: 29700101 DOI: 10.1136/bmjopen-2018-021876] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 4.0] [Reference Citation Analysis]
11 Shieh JTC. Genomic Sequencing Expansion and Incomplete Penetrance. Pediatrics 2019;143:S22-6. [PMID: 30600267 DOI: 10.1542/peds.2018-1099E] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
12 Neu MB, Bowling KM, Cooper GM. Clinical utility of genomic sequencing. Curr Opin Pediatr 2019;31:732-8. [PMID: 31693580 DOI: 10.1097/MOP.0000000000000815] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 3.5] [Reference Citation Analysis]
13 Viberg Johansson J, Langenskiöld S, Segerdahl P, Hansson MG, Hösterey UU, Gummesson A, Veldwijk J. Research participants' preferences for receiving genetic risk information: a discrete choice experiment. Genet Med 2019;21:2381-9. [PMID: 30992550 DOI: 10.1038/s41436-019-0511-4] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 2.7] [Reference Citation Analysis]
14 Webber EM, Hunter JE, Biesecker LG, Buchanan AH, Clarke EV, Currey E, Dagan-Rosenfeld O, Lee K, Lindor NM, Martin CL, Milosavljevic A, Mittendorf KF, Muessig KR, O'Daniel JM, Patel RY, Ramos EM, Rego S, Slavotinek AM, Sobriera NLM, Weaver MA, Williams MS, Evans JP, Goddard KAB; ClinGen Resource. Evidence-based assessments of clinical actionability in the context of secondary findings: Updates from ClinGen's Actionability Working Group. Hum Mutat 2018;39:1677-85. [PMID: 30311382 DOI: 10.1002/humu.23631] [Cited by in Crossref: 20] [Cited by in F6Publishing: 13] [Article Influence: 6.7] [Reference Citation Analysis]
15 Lambert MP. Improving interpretation of genetic testing for hereditary hemorrhagic, thrombotic, and platelet disorders. Hematology Am Soc Hematol Educ Program 2020;2020:76-81. [PMID: 33275718 DOI: 10.1182/hematology.2020000091] [Reference Citation Analysis]
16 Regier DA, Weymann D, Buchanan J, Marshall DA, Wordsworth S. Valuation of Health and Nonhealth Outcomes from Next-Generation Sequencing: Approaches, Challenges, and Solutions. Value Health 2018;21:1043-7. [PMID: 30224107 DOI: 10.1016/j.jval.2018.06.010] [Cited by in Crossref: 21] [Cited by in F6Publishing: 19] [Article Influence: 5.3] [Reference Citation Analysis]
17 Saelaert M, Mertes H, Moerenhout T, Van Cauwenbergh C, Leroy BP, Devisch I, De Baere E. A qualitative study among patients with an inherited retinal disease on the meaning of genomic unsolicited findings. Sci Rep 2021;11:15834. [PMID: 34349199 DOI: 10.1038/s41598-021-95258-2] [Reference Citation Analysis]
18 Gordon DR, Radecki Breitkopf C, Robinson M, Petersen WO, Egginton JS, Chaffee KG, Petersen GM, Wolf SM, Koenig BA. Should Researchers Offer Results to Family Members of Cancer Biobank Participants? A Mixed-Methods Study of Proband and Family Preferences. AJOB Empir Bioeth 2019;10:1-22. [PMID: 30596322 DOI: 10.1080/23294515.2018.1546241] [Cited by in Crossref: 4] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
19 Wang LJ, Zhang CW, Su SC, Chen HH, Chiu YC, Lai Z, Bouamar H, Ramirez AG, Cigarroa FG, Sun LZ, Chen Y. An ancestry informative marker panel design for individual ancestry estimation of Hispanic population using whole exome sequencing data. BMC Genomics 2019;20:1007. [PMID: 31888480 DOI: 10.1186/s12864-019-6333-6] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]